Hisamitsu Pharmaceutical
Phathom Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment landscape for patients suffering from acid-related gastrointestinal disorders. With extensive experience in developing and commercializing innovative therapeutics, they aim to improve the lives of individuals affected by these conditions.
The company's flagship product, VOQUEZNA (vonoprazan), is a prescription medication formulated to heal acid-related damage to the esophagus and provide relief from heartburn associated with various gastrointestinal issues. By focusing on late clinical-stage programs, Phathom Pharmaceuticals is committed to advancing treatments that challenge the status quo of acid-related disorder management.
Generated from the website

